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In Brief
Prato et al. find that mechanoinsensitive
nociceptors account for 50% of all
nociceptors in visceral organs and deep
somatic tissues and are sensitized to
mechanical stimuli by the inflammatory
mediator NGF, suggesting that they
significantly contribute to inflammation-
induced mechanical hyperalgesia.
Cell Reports
ArticleFunctional and Molecular Characterization
of Mechanoinsensitive ‘‘Silent’’ Nociceptors
Vincenzo Prato,1,4 Francisco J. Taberner,1,2,4 James R.F. Hockley,3 Gerard Callejo,3 Alice Arcourt,1 Bassim Tazir,1
Leonie Hammer,1 Paulina Schad,1 Paul A. Heppenstall,2 Ewan S. Smith,3 and Stefan G. Lechner1,5,*
1Institute of Pharmacology, Heidelberg University, Im Neuenheimer Feld 366, 69120 Heidelberg, Germany
2EMBL Monterotondo, Via Ramarini 32, 00016 Monterotondo, Italy
3Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, UK
4These authors contributed equally
5Lead Contact
*Correspondence: stefan.lechner@pharma.uni-heidelberg.de
https://doi.org/10.1016/j.celrep.2017.11.066SUMMARY
Mechanical and thermal hyperalgesia (pain hyper-
sensitivity) are cardinal signs of inflammation.
Although the mechanism underlying thermal hy-
peralgesia is well understood, the cellular andmolec-
ular basis of mechanical hyperalgesia is poorly
described. Here, we have identified a subset of pep-
tidergic C-fiber nociceptors that are insensitive to
noxious mechanical stimuli under normal conditions
but become sensitized to such stimuli when exposed
to the inflammatory mediator nerve growth factor
(NGF). Strikingly, NGF did not affect mechanosensi-
tivity of other nociceptors. We show that these me-
chanoinsensitive ‘‘silent’’ nociceptors are character-
ized by the expression of the nicotinic acetylcholine
receptor subunit alpha-3 (CHRNA3) and that the
mechanically gated ion channel PIEZO2 mediates
NGF-induced mechanosensitivity in these neurons.
Retrograde tracing revealed that CHRNA3+ nocicep-
tors account for 50% of all peptidergic nociceptive
afferents innervating visceral organs and deep so-
matic tissues. Hence, our data suggest that NGF-
induced ‘‘un-silencing’’ of CHRNA3+ nociceptors
significantly contributes to the development of me-
chanical hyperalgesia during inflammation.INTRODUCTION
The somatosensory nervous system comprises a remarkable va-
riety of neurochemically and functionally diverse sensory affer-
ents that enable us to detect and discriminate a wide range of
tactile and noxious stimuli (Dubin and Patapoutian, 2010; Lech-
ner and Lewin, 2013). Sensory neurons that are activated by
noxious stimuli are termed nociceptors and are subclassified
into unmyelinated C-fiber nociceptors and myelinated A-fiber
nociceptors. The vast majority of all nociceptors are sensitive
to mechanical stimuli, but various subpopulations with different
sensitivities to additional noxious stimuli have been described
in awide variety of species. Nociceptors that are exclusively acti-3102 Cell Reports 21, 3102–3115, December 12, 2017 ª 2017 The A
This is an open access article under the CC BY license (http://creativevated by mechanical stimuli are termed C-fiber and A-fiber me-
chanonociceptors; those that additionally respond to noxious
thermal stimuli are collectively termed polymodal nociceptors
but can be further subclassified according to their specific sensi-
tivity to noxious heat and/or cold (Dubin and Patapoutian, 2010;
Lewin and Moshourab, 2004).
The contribution of the various nociceptor subpopulations to
different forms of acute pain is quite well understood. C-fiber no-
ciceptors that express the heat-gated ion channel TRPV1, for
example, are required for the detection of noxious heat and for
the development of heat hyperalgesia (increased pain sensitivity
to heat) (Brenneis et al., 2013; Cavanaugh et al., 2009), and
one study also implicated TRPV1+ afferents in the detection of
noxious pinch stimuli (Brenneis et al., 2013). Moreover, it has
been shown that noxious cold is detected by C-fiber nociceptors
that express the cold- andmenthol-sensitive ion channel TRPM8
(Knowlton et al., 2013). Last, whereas noxious mechanical stim-
uli applied with a blunt probe, such as a von Frey hair, are de-
tected by C-fiber nociceptors that express the Mas-related G
protein-coupled receptor D (Cavanaugh et al., 2009), sharp
and potentially tissue damaging mechanical stimuli, such as a
pinprick, are detected by a subset of A-fiber mechanonocicep-
tors that are characterized by the expression of the neuropeptide
Y receptor type 2 (Arcourt et al., 2017).
However, one subpopulation of nociceptors, the so-called
silent nociceptors, has remained enigmatic ever since it was first
described (Gold and Gebhart, 2010; Michaelis et al., 1996). The
term ‘‘silent nociceptor’’ was originally introduced to describe
sensory afferents that fired action potentials in response to elec-
trical stimulation of the receptive field but could not be activated
by physiologically relevant noxious mechanical stimuli. Silent
nociceptors have been found in large numbers in the urinary
bladder, the distal colon, and the knee joint (Feng and Gebhart,
2011; Gebhart, 1999; Ha¨bler et al., 1990; Schaible and Schmidt,
1988) but are rare in rodent skin (Wetzel et al., 2007). In human
skin, however, silent afferents account for almost one quarter
of all C-fiber nociceptors (Schmidt et al., 1995). The fact that
silent nociceptors are normally not activated by mechanical
stimuli, suggests that they are not involved in mechanical
pain signaling in healthy individuals. However, several studies
have shown that silent afferents are sensitized to mechanical
stimuli by a variety of compounds that are commonly used to
experimentally induce inflammation, as well as by endogenousuthor(s).
commons.org/licenses/by/4.0/).
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Figure 1. CHRNA3+ Neurons Do Not Transduce Mechanical Stimuli into Electrical Signals
(A) Schematic illustration of the technique used to evoke and record mechanically activated currents.
(B) Example traces of whole-cell currents (bottom traces) evoked by mechanical stimulation (top traces) in the indicated cell types.
(C) The mean ± SEM peak mechanotransduction current amplitudes are shown as a function of membrane displacement.
(D) Comparison of the proportions of mechanoinsensitive (n.r.) and mechanosensitive neurons in the indicated sensory neuron subpopulations.
(E) Overlay of phase-contrast and fluorescence image of an IB4-labeled DRG culture from a CHRNA3-EGFP mouse.
(F) Typical AP of the indicated cell types (top traces). The bottom traces show the first derivative (dV/dt) of the AP, which exhibits two local minima if the AP has the
nociceptor-specific hump in the falling phase.
(G) Comparison of the mean (bars) ± SEM (error bars) half-peak durations (HPDs) of the APs of the indicated cell types. The scattered symbols show the individual
HPD values of each recorded cell. Kruskal-Wallis one-way ANOVA with Dunn’s multiple-comparison test.
(H) Size distribution histogram of cultured DRG neurons showing that CHRNA3+ neurons have medium cell diameters.inflammatorymediators such as nerve growth factor (NGF) (Feng
et al., 2012; Gold and Gebhart, 2010; Hirth et al., 2013; Schaible
and Schmidt, 1985). Considering the large proportion of me-
chanically insensitive afferents in the aforementioned tissues, it
is conceivable that un-silencing them would greatly increase
nociceptive input to pain processing circuits in the spinal cord
and higher brain regions. Accordingly it has been proposed
that silent afferents may significantly contribute to mechanical
hyperalgesia during inflammation (Gold and Gebhart, 2010).
However, because of the lack of molecular markers that would
allow the unequivocal identification or the selective functional
manipulation of silent afferents, this hypothesis has never been
directly tested. Moreover, the molecular mechanism that medi-ates the un-silencing of silent nociceptors has not yet been
described.
RESULTS
CHRNA3+ Sensory Neurons Are Mechanoinsensitive
Peptidergic C-Fiber Nociceptors
Mechanosensitivity of dorsal root ganglion (DRG) sensory neu-
rons is usually examined using the patch-clamp technique by
recording whole-cell transmembrane currents evoked by me-
chanical stimulation of the cell soma (Figure 1A). In DRG
neurons, three types of mechanically activated currents, which
differ in their inactivation kinetics and were thus termed rapidlyCell Reports 21, 3102–3115, December 12, 2017 3103
adapting (RA), intermediately adapting (IA), and slowly adapting
(SA) currents, have been described (Drew et al., 2002; Hu and
Lewin, 2006; McCarter et al., 1999; Ranade et al., 2014). The
ion channel PIEZO2 mediates the RA current in low-threshold
mechanoreceptors (LTMRs), which detect tactile stimuli, but
the mechanically gated channel required for mechanotransduc-
tion in nociceptors is still unknown (Ranade et al., 2014; Schrenk-
Siemens et al., 2015). While we were screening several reporter
mouse lines with the original goal of testing whether IA and SA
currents are confined to genetically defined subsets of nocicep-
tors, we made the observation that neurons in which EGFP is
expressed under the control of the promoter of the nicotinic
acetylcholine receptor subunit alpha-3 (CHRNA3) do not
respond to mechanical stimuli at all. Thus only 1 of 15 tested
CHRNA3+ cells exhibited a tiny inward current in response to
mechanical stimulation of the soma (Figures 1B–1D). In contrast,
the majority of peptidergic C-fiber nociceptors (27 of 32 tested
neurons), non-peptidergic nociceptors (13 of 17), and LTMRs
(18 of 21) exhibited large mechanically evoked inward currents
(Figures 1B–1D), which was consistent with previously published
data (Drew et al., 2002; Hu and Lewin, 2006; Ranade et al., 2014).
In these recordings, LTMRs and nociceptors were distinguished
by means of cell size as well as action potential (AP) shape and
duration, as previously described (Fang et al., 2005; Koerber
et al., 1988). Peptidergic and non-peptidergic nociceptors
were further discriminated by isolectin B4 (IB4) labeling, which
specifically binds to non-peptidergic nociceptors (Figure 1E)
(Molliver et al., 1997). Thus, small-diameter IB4-negative neu-
rons with wide APs that exhibited the nociceptor-specific
hump in the falling phase were classified as peptidergic C-fiber
nociceptors, and large-diameter neurons with narrow unin-
flected spikes were classified as LTMRs (Figures 1E–1G).
CHRNA3+ neurons exhibited APs that were indistinguishable
from those of other nociceptors but were significantly different
from the APs of LTMRs (Figures 1F and 1G). Moreover,
CHRNA3+ neurons were not labeled by IB4 (Figure 1E), had small
to medium-size cell bodies, and accounted for 7.8% ± 1.6%
(n = 636) of the total population in cultures of L2–L5 DRGs
(Figure 1H). To test if CHRNA3+ neurons, as suggested by their
AP configuration, are indeed nociceptors, we next examined
the expression of well-established nociceptor subpopulation
markers in CHRNA3+ neurons in L3–L5 DRGs (Figures 2A–2D).
The great majority of CHRNA3+ neurons expressed the NGF re-
ceptor TRKA (94.6% ± 4.1%; Figures 2A and 2D) and the calci-
tonin gene-related peptide (CGRP) (90.5% ± 2.5%; Figures 2C
and 2D), which are markers for peptidergic nociceptors (Averill
et al., 1995), but did not express the glial cell line-derived neuro-
trophic factor (GDNF) receptor RET (1.8% ± 3.0%; Figures 2B
and 2D), which is present in non-peptidergic neurons (Molliver
et al., 1997). Moreover, only a few CHRNA3+ neurons showed
immunoreactivity for neurofilament heavy polypeptide (NEFH)
(11.6% ± 5.4%; Figures 2A and 2D), which is expressed only
in myelinated sensory neurons. The central projections of
CHRNA3+ neurons predominantly terminated in lamina I of the
dorsal horn of the spinal cord, which is also characteristic of pep-
tidergic nociceptors (Figure 2E). We also observed EGFP immu-
noreactivity in local neurons in lamina IIo of the dorsal horn and
scattered throughout lamina III. However, unlike the EGFP sig-3104 Cell Reports 21, 3102–3115, December 12, 2017nals in lamina I, the signals in deeper laminae did not overlap
with CGRP immunofluorescence (see insets in Figure 2E)
and thus unlikely originate from CHRNA3+ sensory afferents.
Hence the electrophysiological data together with the immu-
nohistochemical analysis strongly suggest that CHRNA3+
neurons are mechanically insensitive, ‘‘silent,’’ peptidergic C-fi-
ber nociceptors.
CHRNA3+ Neurons Densely Innervate Deep Somatic
Tissues and Viscera but Are Absent from the Skin
Silent nociceptors have originally not only been found in the knee
joint (Schaible and Schmidt, 1985), which is innervated by L3–L4
DRG neurons that we had investigated so far, but were shown to
be even more abundant in visceral organs (Michaelis et al.,
1996). Hence we next examined CHRNA3 expression in other
spinal segments. Indeed, CHRNA3+ neurons were present in
all DRGs from cervical (C1) to sacral (S1), and almost all of
them expressed CGRP (Figures 2F and S1A). More important,
this analysis revealed that CHRNA3+ neurons are rather rare in
most DRGs (15% of all CGRP+ neurons) but account for up
to 40% of the CGRP+ population in thoracolumbar (T12–L1)
and lumbosacral (L6–S1) DRGs (Figures 2F and 2G). This finding
strongly supports our hypothesis that CHRNA3+ neurons are si-
lent nociceptors, because these DRGs give rise to the lumbar
splanchnic nerve and the pelvic nerve, which innervate the colon
and the bladder, where silent afferents have been found in large
numbers (Christianson et al., 2007; Michaelis et al., 1996). While
analyzing the immunolabeled sections, we noticed the presence
of numerous neurons with extremely bright GFP fluorescence in
lumbosacral DRGs (Figures 2F and S1B). Indeed, the GFP inten-
sity distributions in L6–S1 DRGs and in T12–L1 DRGs were best
fit with the sumof twoGaussians, whereas theywere better fitted
with a single Gaussian in all other DRGs, suggesting that two
different populations of CHRNA3+ neurons that significantly
differ in their GFP intensities (hereafter termed GFPlow and
GFPhigh neurons) are present in thoracolumbar and lumbosacral
DRGs (Figure S1C). GFPlow neurons had significantly higher
levels of CGRP compared with GFPhigh neurons (Figure S1D),
suggesting that these two populations may also differ in their
functional properties. To test this hypothesis, we examined the
mechanosensitivity of the two populations in various spinal seg-
ments. GFPlow neurons from all spinal segments as well as
GFPhigh neurons from the thoracolumbar region were insensitive
to mechanical stimuli, whereas GFPhigh neurons from lumbosa-
cral DRGs exhibited large mechanotransduction currents (Fig-
ures S2A and S2B). Hence, unless otherwise stated, hereafter
the term ‘‘CHRNA3+ neurons’’ refers to the mechanoinsensitive
GFPlow population.
We next examined the peripheral projections of CHRNA3+
neurons (Figures 3A–3F). In the distal colon and the urinary
bladder, CHRNA3+ fibers accounted for 92.1% ± 0.8% and
81.1% ± 0.5% of all CGRP+ fibers, respectively (Figures 3B,
3C, and 3F). Moreover, we observed numerous CHRNA3+ affer-
ents in the knee joint (63.2 ± 0.7% of CGRP+ fibers; Figures 3D
and 3F) and the gastrocnemius muscle (62.5% ± 2.3% of
CGRP+ fibers; Figures 3E and 3F), but we did not find any
CHRNA3+ fibers in the glabrous and hairy skin (Figures 3A and
S3A). Some sympathetic neurons, which also innervate the
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examined tissues, also expressed CHRNA3. However, these
cells did not express CGRP (Figures S3B and S3C), supporting
the hypothesis that the CHRNA3+/CGRP+ fibers shown in Fig-
ures 3B–3E indeed originate from CHRNA3+ sensory neurons.
Heterogeneity in the GFP intensities, as observed in DRG stain-
ings (Figures 2F, S1B, and S1C), was not evident in stainings of
the bladder and the colon. Hence, to clarify whether the
observed CHRNA3+ fibers originated from GFPlow or GFPhigh
neurons, we next labeled sensory neurons that innervate the
bladder and the colon with the retrograde tracer fast blue (FB)
(Figures 4A and 4B). In T13 DRGs, 39.1% ± 3.2% of the
CGRP+ neurons that innervate the colon were GFPlow, whereas
fewer than 10% were GFPhigh. By contrast in S1 DRGs, both
GFPlow (55% ± 6% of FB+/CGRP+ neurons) and GFPhigh
(37.2% ± 14.4%) neurons were labeled by FB injection into the
colon (Figures 4A, 4D, and 4E). Similar results were obtained
for the bladder, where FB injection labeled both GFPlow
(40.5% ± 4.9%) and GFPhigh (41.2% ± 0.7%) neurons in S1
DRGs but almost exclusively GFPlow cells (36.1% ± 12.7%) in
T13 DRGs (Figures 4B and 4F). We also labeled knee joint affer-
ents, which predominantly originate from L3 and L4 DRGs (da
Silva Serra et al., 2016). Consistent with our previous results (Fig-
ure 3F), 56.2% ± 15.4% and 42.1% ± 10.7% of the FB+/CGRP+
neurons in L4 and L3 DRGs, respectively, were CHRNA3 positive
(Figures 4C and 4G).
Hence, taken together, our data demonstrate that mechanoin-
sensitive CHRNA3+ sensory neurons account for approximately
half of all peptidergic nociceptors in tissues previously shown to
be densely innervated by silent afferents (Feng and Gebhart,
2011; Gebhart, 1999; Ha¨bler et al., 1990; Schaible and Schmidt,
1988).
CHRNA3+ Neurons Are Sensitized to Mechanical Stimuli
by NGF
A key feature of silent nociceptors is their ability to become
sensitized to mechanical stimuli by inflammatory mediators.
We thus next asked if CHRNA3+ (GFPlow from L2–L5 DRGs) neu-
rons acquire mechanosensitivity after treatment with NGF
(50 ng/mL) or an inflammatory soup containing 10 mMbradykinin,
10 mM prostaglandin E2, 10 mM histamine, and 10 mM serotonin.
One hour treatment with NGF or the inflammatory soup did not
affect mechanosensitivity of CHRNA3+ neurons (Figures 5A–5C
and S4; note that both treatments were applied after the cells
had been cultured in normal growth medium for 24 hr). After
24 hr treatment with NGF, however, CHRNA3+ neurons acquired
mechanosensitivity and responded to mechanical stimulation
with large inward currents, which did not further increase when
NGF and inflammatory soup were applied together (Figures
5A–5C and S4). Interestingly, NGF did not modulate the(E) CHRNA3+ fibers project to lamina I, which was visualized with CGRP staining
(compare signals marked by arrowheads and asterisks in the inset) and hence like
with arrows).
(F) Representative images showing co-expression of CHRNA3 and CGRP in th
particularly bright CHRNA3 immunofluorescence. For a detailed analysis of the
bright CHRNA3+ neurons, see Figures S1 and S2.
(G) Overview of the proportions of CGRP+ neurons that express CHRNA3 in the
mean ± SEM (N = 2 mice, percentage of individual mice are shown as black circ
3106 Cell Reports 21, 3102–3115, December 12, 2017amplitude or the kinetics of mechanotransduction currents in
small-diameter IB4-negative neurons, that is, putative TRKA-ex-
pressing peptidergic C-fiber nociceptors (Figures 5D–5F). In-
flammatory soup alone also had no effect on mechanosensitivity
of IB4-negative neurons. However, after 24 hr treatment with
NGF, 1 hr treatment with the inflammatory soup caused a small
but significant increase of mechanotransduction current ampli-
tudes elicited by small membrane displacements (Figure 5E),
as well as a slowing of inactivation kinetics (Figure 5F).
Via binding to the TRKA receptor, NGF can activate multiple
signaling pathways, including the PLCg pathway, the PI3-kinase
pathway, and the Ras/Raf/MEK/ERK pathway (Denk et al.,
2017). To examine which of these signaling pathways mediated
the sensitization of CHRNA3+ neurons, we next incubated DRG
cultures for 24 hr with NGF in the presence of 5 mM U73122, a
PLCg blocker, 500 nMwortmannin (WTM), a PI3-kinase blocker,
or 10 mM U0126, an ERK1/2 blocker (Figure 6A). U73122 and
WTM did not alter the effect of NGF treatment, but CHRNA3+
neurons treated with U0126 exhibited significantly smaller me-
chanotransduction currents than neurons from the same cul-
tures treated with NGF alone (Figure 6B). ERK1/2 kinases can
regulate gene transcription but can also directly modulate ion
channels by phosphorylation. To test if the former mechanism
is involved, we incubated CHRNA3+ neurons for 24 hr with
NGF in the presence of the transcription blocker actinomycin D
(2 mg/mL). Indeed, mechanotransduction currents were signifi-
cantly smaller when cultures were treated with actinomycin D
(Figure 6B), suggesting that de novo gene transcription is
required for the NGF-induced acquisition of mechanosensitivity
in CHRNA3+ neurons.
We next sought to identify the ion channel that confers mecha-
nosensitivity on CHRNA3+ neurons. In LTMRs, RA-type mecha-
notransduction currents are mediated by PIEZO2, but the ion
channel that mediates mechanotransduction currents in noci-
ceptors is still unknown (Ranade et al., 2014). Several proteins
have been implicated in mechanosensitivity of sensory neurons
such as the acid-sensing ion channels ASIC2 and ASIC3 (Price
et al., 2000, 2001), the transient receptor potential channels
TRPA1 (Vilceanu and Stucky, 2010), TRPC3 and TRPC6 (Quick
et al., 2012) and TMEM150c (Hong et al., 2016), but conflicting
results have been published regarding their precise role in me-
chanotransduction (Drew et al., 2004; Dubin et al., 2017). To
test if any of these putative mechanotransduction genes was
present in CHRNA3+ neurons and upregulated by NGF, we
next compared their mRNA levels in CHRNA3+ neurons from
L2–L5 DRGs cultured for 24 hr in the presence and absence of
NGF using qPCR (Figure 7A). This analysis showed that tran-
scripts for none of these proteins were upregulated by NGF. Un-
expectedly, however, the qPCR data revealed that even under. CHRNA3+ fibers in lamina IIo (IB4-positive) and below were CGRP negative
ly originate from the CHRNA3+/CGRP– local neurons in lamina II (cells marked
oracic, lumbar, and sacral DRGs. In sacral DRGs, numerous neurons exhibit
neurochemical and electrophysiological differences between bright and less
indicated DRGs (C, cervical; T, thoracic; L, lumbar; S, sacral). Bars represent
les).
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Figure 3. Peripheral Projections of CHRNA3+ Neurons
(A–E) Immunostainings of tissue sections of the glabrous skin (A), the distal colon (B), the urinary bladder (C), the knee joint (D), and the gastrocnemius muscle (E)
to visualize innervation by CHRNA3+/CGRP+ sensory afferents. Also see Figure S3. Images shown in (A) are composite images assembled from multiple high-
resolution images. The three images on the right in (B)–(D) show magnified views of the regions marked with the dashed white squares in the leftmost images.
(F) Quantification of the proportion of CGRP+ fiber fragments (i.e., each connected fluorescent entity was considered as a fiber fragment) that express CHRNA3.
Bars represent mean ± SEM (N = 2–4 mice; individual data points from each mouse are shown as black circles).
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(A–C) Representative images of DRG neurons retrogradely labeled with fast blue (FB) from the colon (A), the bladder (B), and the knee joint (C) and co-stained for
CHRNA3 and CGRP. Arrowheads in (A)–(C) mark GFPlow-CHRNA3+ neurons, and arrows mark GFPhigh-CHRNA3+ neurons.
(D) Schematic illustration of the origin of sensory afferents that innervate the colon, the bladder, the knee joint, and the gastrocnemius muscle.
(E–G) Quantification of the percentage of CHRNA3+-GFPlow (mechanoinsensitive) and CHRNA3+-GFPhigh (mechanosensitive) among FB+/CGRP+ in T13, S1, and
L3–L4 DRGs, that is, among CGRP+ afferents that innervate the colon (E), the bladder (F), and the knee joint (G). Bars represent mean ± SEM (N = 2 or 3 mice;
proportions of individual mice are shown as black circles). Note that CHRNA3-GFPlow (mechanoinsensitive) afferents account for50% of all CGRP+ afferents in
the bladder, colon, and knee joint.control conditions, CHRNA3+ neurons express PIEZO2 at levels
comparable with those in LTMRs. The presence of PIEZO2 was
further confirmed by immunolabeling of L2–L5 DRGs, which
showed that 94.9% (278 of 293) of the CHRNA3+ neurons ex-
press PIEZO2 (Figure 7B), suggesting that mechanotransduction3108 Cell Reports 21, 3102–3115, December 12, 2017currents in CHRNA3+ neurons are indeed mediated by PIEZO2.
This hypothesis was supported by additional electrophysiolog-
ical experiments showing that similar to PIEZO2-mediated cur-
rents (Coste et al., 2010), mechanotransduction currents in
CHRNA3+ neurons reversed at close to 0 mV and exhibited
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Figure 5. NGF Sensitizes CHRNA3+ Neu-
rons but Not IB4neg Neurons to Mechanical
Stimuli
(A) Representative example traces of whole-cell
currents (bottom traces) evoked by mechanical
stimulation (top traces) in CHRNA3+ neurons
cultured for 24 hr in normal growth medium (con-
trol), for 24 hr in growth medium + 1 hr inflamma-
tory soup before recording (inf. soup), after 24 hr
treatment with 50 ng/mL NGF (+NGF), and after
24 hr NGF + 1 hr inflammatory soup.
(B) Comparison of the displacement-response
curves of CHRNA3+ neurons after the indicated
treatments (data points represent mean ± SEM
mechanotransduction current amplitudes). Cur-
rent amplitudes evoked by the same membrane
displacement in the different conditions were
compared using Kruskal-Wallis one-way ANOVA
and Dunn’s multiple-comparison test. The
p values of Dunn’s multiple-comparison test are
indicated by asterisks for control versus 24 hr NGF
and by a pound sign for control versus 24 hr NGF +
1 hr soup.
(C) Comparison of the inactivation time constants
(tinact) of the mechanotransduction currents re-
corded in the indicated conditions. Bars represent
mean ± SEM tinact. Individual data points from
which the means were calculated are shown in the
aligned dot plot. Also see Figure S4.
(D–F) Same parameters as in (A)–(C) but for
mechanotransduction currents evoked in small
diameter IB4neg neurons: (D) whole-cell currents,
(E) displacement-response curves, and (F) inacti-
vation time constants. Note that NGF neither
modulates mechanotransduction current ampli-
tudes nor inactivation kinetics.significantly slower inactivation kinetics at positive membrane
potentials (Figures 7C–7E). Moreover, mechanotransduction
currents in CHRNA3+ neurons were inhibited by the toxin
GsMTx4 (Figure 7F), which had been shown to block
PIEZO2 currents (Wang et al., 2017). Finally, small interfering
RNA (siRNA)-mediated knockdown of PIEZO2 expression in
CHRNA3+ neurons prevented the acquisition of mechanosensi-
tivity in NGF-treated cells (Figures 7G and 7H).
In summary, our data show that PIEZO2 confers mechano-
sensitivity to CHRNA3+ neurons. However, because PIEZO2
is also expressed in the absence of NGF (i.e., under conditions
in which CHRNA3+ neurons do not exhibit mechanotransduc-
tion currents) our data further suggest that PIEZO2 is normally
inhibited in these cells and is released from this inhibition
by NGF-induced upregulation of a yet unidentified protein
(Figure 7I).Cell ReportsDISCUSSION
Here, we have identified a molecular
marker for mechanoinsensitive ‘‘silent’’
nociceptors. We show that sensory neu-
rons that express CHRNA3 constitute a
subset of peptidergic C-fiber nociceptors
that are completely insensitive to me-chanical stimuli under normal conditions but become sensitized
to such stimuli when exposed to the inflammatorymediator NGF.
Strikingly, the mechanosensitivity of other nociceptors does not
appear to be affected by NGF treatment. We further show that
the mechanically gated ion channel PIEZO2 mediates NGF-
induced mechanosensitivity in CHRNA3+ nociceptors. Because
CHRNA3+ afferents account for 50% of all peptidergic noci-
ceptors innervating visceral organs and deep somatic tissues,
we propose that the NGF-induced un-silencing of CHRNA3+
afferents significantly contributes to the development of me-
chanical hyperalgesia during inflammation.
The Contribution of CHRNA3+ Neurons to Inflammation-
Induced Mechanical Hyperalgesia
NGF plays an important role in the induction and maintenance of
pain hypersensitivity associated with inflammation (Denk et al.,21, 3102–3115, December 12, 2017 3109
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Figure 6. The Acquisition of Mechanosen-
sitivity Requires De Novo Gene Tran-
scription
(A) Schematic illustration of the intracellular
signaling cascades activated by NGF.
(B) Example traces (left) and displacement-
response curves (right) of mechanotransduction
currents of CHRNA3+ neurons treated with NGF
and the indicated inhibitors of the signaling
cascades shown in (A). Current amplitudes
evoked by the same membrane displacement in
the different conditions were compared using
Kruskal-Wallis one-way ANOVA and Dunn’s multiple-comparison test. The p values of Dunn’s multiple-comparison test are indicated by asterisks for 24 hr NGF
versus control, by pound signs for NGF + U73122 versus control, and by section signs for NGF + WTM versus control.2017; Lewin et al., 2014), which is highlighted by several impor-
tant observations. Thus, a single NGF injection induces profound
and long-lasting thermal andmechanical hyperalgesia in rodents
and humans (Dyck et al., 1997; Lewin et al., 1993; Rukwied et al.,
2010). Moreover, sequestering endogenously produced NGF
with anti-NGF antibodies blocks hyperalgesia associated with
experimentally induced inflammation in rodents (Woolf et al.,
1994) and, most important, alleviates pain in humans suffering
from a variety of painful chronic inflammatory diseases (Chang
et al., 2016; Denk et al., 2017). Although the mechanism under-
lying NGF-induced heat hyperalgesia is well understood, little
is known about the cellular and molecular basis of mechanical
hyperalgesia.
Our data suggest that CHRNA3+ silent nociceptors may
contribute to the development of inflammatory mechanical
hyperalgesia in visceral organs, muscles, and joints, via the
following mechanism: under normal conditions, CHRNA3+ neu-
rons are mechanoinsensitive (Figures 1A–1D), and hence
noxious mechanical stimuli only activate other mechanosensi-
tive nociceptors, leading to normal pain perception (Figure 7I).
During inflammation, however, increased NGF levels in the in-
flamed tissues (Chen et al., 2016; Denk et al., 2017) lead to un-
silencing of CHRNA3+ afferents (Figures 5A–5C). Considering
that silent afferents account for50% of all nociceptors in these
tissues (Figure 4), the consequence of this un-silencing is that the
number of nociceptive afferents that are activated by a given
noxious mechanical stimulus is doubled, which inevitably results
in significantly increased excitatory drive onto projection neu-
rons in the spinal cord and hence to increased pain sensitivity
(Figure 7I).
So is this model in accordance with previously published data
and models regarding possible mechanisms of mechanical hy-
peralgesia? First, we would like to emphasize that we do not
claim that the un-silencing of CHRNA3+ afferent is the only
mechanism underlying NGF-induced hyperalgesia. Our findings
do not rule out a possible contribution of previously described
mechanisms such as NGF-induced increases in the synthesis
and release of brain-derived neurotrophic factor (BDNF) from
the central synapses of nociceptors, which leads to strength-
ened synaptic transmission and hence amplified pain signaling,
or NGF-induced changes in the electrical excitability of nocicep-
tors resulting from subtle changes in the expression levels and
the functional properties of the voltage-gated sodium channels
Nav1.7 and Nav1.8 (Lewin et al., 2014; Pezet and McMahon,3110 Cell Reports 21, 3102–3115, December 12, 20172006). However, given the remarkable sensitivity to NGF (Fig-
ure 5) and the high incidence of CHRNA3+ afferents in viscera
and deep somatic tissues (Figures 3 and 4), it is tempting to
speculate that the contribution of CHRNA3+ afferents to pain hy-
persensitivity in these tissues is quite considerable. Indeed,
there is compelling clinical evidence indicating that NGF-
signaling plays a particularly important role in the development
of pain hypersensitivity in the joints, in the bladder, and in mus-
cles. Thus numerous clinical trials have demonstrated that
anti-NGF therapy shows particularly great efficacy in alleviating
pain associated with osteoarthritis, interstitial cystitis, and low
back pain (Chang et al., 2016; Denk et al., 2017). Our observation
that mechanoinsensitive CHRNA3+ afferents account for
approximately 50% of all peptidergic nociceptors in the colon,
the bladder, the knee joint, and muscles (Figures 3 and 4) is
consistent with previous electrophysiological studies, which
found that the proportion of silent afferents among C-fiber noci-
ceptors is between 30% and 90% in these tissues (Feng and
Gebhart, 2011; Gebhart, 1999; Gold and Gebhart, 2010; Ha¨bler
et al., 1990; Michaelis et al., 1996; Schaible and Schmidt, 1985).
Silent afferents have also been found in large numbers (25%) in
cutaneous nerves of humans and monkeys (Meyer et al., 1991;
Schmidt et al., 1995), but they appear to be extremely rare
(<10% of all C-fiber nociceptors) in the mouse skin (Wetzel
et al., 2007). Hence, the absence of CHRNA3+ afferents from
both hairy and glabrous skin (Figures 3A and S3A) was not fully
unexpected. It is unlikely that we overlooked CHRNA3+ afferents
innervating the skin, considering that we have analyzed a total of
120 skin sections from three different mice. Hence, we propose
that silent cutaneous afferents are genetically different from
those innervating the viscera and deep somatic tissues.
The Effects of NGF on Mechanosensitivity
Another important finding of our study was that NGF sensitizes
only CHRNA3+ neurons but not other TRKA-expressing nocicep-
tors (IB4neg neurons), to mechanical stimuli (Figure 5). At first
glance, the finding that IB4neg neurons are not sensitized to me-
chanical stimuli appears to contradict previous reports from
others and us, showing that mechanotransduction currents in
IB4neg neurons are modulated by NGF (Di Castro et al., 2006;
Lechner et al., 2009). In this context, it is important to note that
here we have used adult animals (8–12 weeks old), whereas in
our previous study, we examined neurons from newborn mice
(Lechner et al., 2009), and Di Castro et al. (2006) studied juvenile
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Figure 7. Mechanotransduction in CHRNA3+ Neurons Requires PIEZO2
(A) Comparison of the expression levels of the indicated genes in CHRNA3+ neurons under control conditions (green bars) and after 24 hr treatment with NGF
(hatched bars). Note that under control conditions CHRNA3+ neurons express Piezo2 at similar levels as Ab-LTMRs (black bar). Bars represent mean ± SEM from
three or four samples (one sample per mouse).
(B) Immunolabeling of an L4 DRG showing PIEZO2 expression in CHRNA3+ neurons (marked by arrowheads).
(C) Example traces of mechanotransduction currents evoked by a 4.8 mmmembrane displacement of a CHRNA3+ neuron at the indicated membrane potentials.
Inactivation was fitted with a single exponential function (red dashed line).
(D) Paired dot plot comparing inactivation time constants (tinact) of mechanotransduction currents at 60 mV and +60 mV. At +60 mV, currents inactivate
significantly slower than at 60 mV (paired t test, p = 0.0012).
(E) I-V curve showing that mechanotransduction currents in CHRNA3+ neurons after 24 hr NGF treatment reverse at around 0 mV, suggesting that they are
mediated by a non-selective cation channel. Symbols represent mean ± SEM (n = 11).
(F) Example traces (left) and paired dot plot (right) showing that mechanotransduction currents in CHRNA3+ neurons are inhibited by GsMTx4 (n = 8, paired t test,
p = 0.0118).
(G) Comparison of the Piezo2 expression levels in CHRNA3+ neurons transfected with non-targeting siRNA (scrambled) and Piezo2-siRNA, showing that Piezo2
expression was reduced by 72% (0.032 ± 0.0031 versus 0.0091 ± 0.0025; Mann-Whitney test, p = 0.0357).
(H) Comparison of the displacement-response curves of NGF-treated CHRNA3+ neurons transfected with non-targeting siRNA (green circles) and Piezo2-siRNA
(black circles). Curves were compared using a two-way repeated-measures ANOVA (p = 0.016) with Bonferroni post-test.
(I) Model of the mechanism underlying the acquisition of mechanosensitivity and the possible contribution to increased pain sensitivity during inflammation.
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rats. However, it is well known that NGF is important for the func-
tional maturation of sensory neurons during embryonic and post-
natal development of sensory neurons (Lewin et al., 2014; Luo
et al., 2007). We have actually shown that NGF is required for
the developmental acquisition of mechanosensitivity in IB4neg
neurons (Lechner et al., 2009). Moreover, it was shown that the
diversification of nociceptors into peptidergic TRKA+ neurons
and non-peptidergic TRKA–/RET+ neurons is only completed
3 weeks after birth (Bennett et al., 1996; Molliver and Snider,
1997; Molliver et al., 1997). Hence NGF-dependent effects
observed in newborn or juvenile animals should be interpreted
with caution, as they might solely reflect incomplete maturation
of nociceptors. Indeed, using extracellular single-unit recordings
from the saphenous nerve, it was recently shown that in the com-
plete Freund’s adjuvant (CFA) model of inflammation, peripheral
sensitization of cutaneous nociceptors occurs only in young but
not in aged mice (Weyer et al., 2016). So does that mean that the
mechanosensitivity of CHRNA3-negative peptidergic nocicep-
tors is not at all altered during inflammation and that NGF does
not in general modulate the functional properties of these neu-
rons? Not quite. Although our data show that NGF does not
directly modulate mechanotransduction currents in IB4neg neu-
rons, we demonstrate that an inflammatory soup potentiates
mechanotransduction currents only after pretreatment with
NGF (Figure 5E). A possible explanation for this observation is
that NGF upregulates the expression of genes that are required
for the actions of other inflammatory mediators. Indeed, it has
been shown that the B2 receptor for bradykinin, which was pre-
sent in the inflammatory soup used in this study, is upregulated in
nociceptors by NGF (Lee et al., 2002). Moreover, Di Castro et al.
(2006) showed that in juvenile rats, direct activation of protein
kinase C with the phorbol ester PMA sensitizes mechanotrans-
duction currents in IB4neg neurons only after pretreatment with
NGF. Hence, we conclude that in addition to inducing a complete
phenotypic switch in CHRNA3+ neurons, NGF primes other pep-
tidergic nociceptors for subsequent sensitization by other in-
flammatory mediators, which, however, have only moderate
effects on mechanosensitivity.
The Molecular Basis of NGF-Induced
Mechanosensitivity in CHRNA3+ Neurons
During the past two decades, numerous ion channels, such
as ASIC channels, TRPA1, TRPC3, TRPC6, TMEM150c, and
PIEZO2, have been proposed to contribute to mechanosensitiv-
ity of sensory neurons (Hong et al., 2016; Price et al., 2000, 2001;
Quick et al., 2012; Ranade et al., 2014; Vilceanu and Stucky,
2010). However, conflicting results have been published
regarding the precise role of some of these channels in mecha-
notransduction (Drew et al., 2004; Dubin et al., 2017). The only
channel that has convincingly been shown to be required for me-
chanosensitivity of sensory neurons is PIEZO2. First, unlike the
other aforementioned channels, PIEZO2 alone is sufficient to
produce mechanotransduction currents when expressed in het-
erologous systems (Coste et al., 2010). Moreover, PIEZO2
knockout mice have severe deficits in proprioception (Woo
et al., 2015) and in gentle touch perception (Ranade et al.,
2014). Interestingly, PIEZO2 knockout mice do not seem to
have problems detecting noxious mechanical stimuli and do3112 Cell Reports 21, 3102–3115, December 12, 2017develop hyperalgesia in the paw skin in the CFAmodel of inflam-
mation (Ranade et al., 2014). However, PIEZO2 is expressed in
almost 50% of all sensory neurons (Ranade et al., 2014), some
of which express the heat-gated ion channel TRPV1 (Coste
et al., 2010), suggesting that PIEZO2 is also present in some no-
ciceptors. Using qPCR and immunohistochemistry, we show
that PIEZO2 is indeed expressed in some nociceptors, namely,
in CHRNA3+ neurons (Figures 7A and 7B). Moreover, the cur-
rent-voltage relationship together with the voltage dependence
of the inactivation kinetics and the GsMTX4-sensitivity (Figures
7C–7F), and, most important, the observation that siRNA-medi-
ated knockdown of PIEZO2 renders NGF-treated CHRNA3+
neurons insensitive to mechanical stimuli (Figures 7G and 7H),
suggests that the NGF-induced mechanotransduction currents
in CHRNA3+ neurons are indeed mediated by PIEZO2. So why
is it that PIEZO2 knockout mice do not have a pain phenotype?
The simple answer is that Ranade et al. (2014) examined only
cutaneous nociceptors, but as our data demonstrate, CHRNA3+
afferents do not innervate the skin. An important question that re-
mains open, however, is why CHRNA3+ neurons are insensitive
to mechanical stimuli under control conditions even though they
express PIEZO2 (Figures 7A and 7B). At present we can only
speculate about the possible mechanism. Our experiments,
however, demonstrate that de novo gene transcription is
required for the acquisition of mechanosensitivity (Figures 6A
and 6B). Hence, as illustrated in Figure 7I, we propose that
PIEZO2 is normally inhibited by a yet unknown protein and is
released from this inhibition by another unidentified protein
that is upregulated by NGF-TRKA-ERK1/2 signaling.
Conclusions
NGF signaling plays a central role in the development of me-
chanical hyperalgesia associated with inflammation. Despite
the great efficacy of anti-NGF antibodies in alleviating pain, how-
ever, in 2010 all anti-NGF trials were placed on clinical hold for a
period of almost 5 years, because of a high incidence of joint
destruction in osteoarthritis patients receiving anti-NGF treat-
ment and concerns regarding possible side effects on sympa-
thetic neurons (Chang et al., 2016; Denk et al., 2017). Our
work, especially the identification of a nociceptor subpopulation
that is particularly sensitive to NGF and that predominantly inner-
vates tissues in which anti-NGF therapy has proved extremely
efficacious, provides an invaluable framework for future studies
that aim to further unravel the mechanism underlying NGF-
induced hyperalgesia and studies aimed at developing drugs
that selectively block the effects of NGF in sensory neurons
and would thus potentially have fewer side effects than currently
available anti-NGF drugs.
EXPERIMENTAL PROCEDURES
Animals
CHRNA3-EGFP mice, official name Tg(Chrna3-EGFP)BZ135Gsat/Mmnc
(RRID: MMRRC_000243-UNC), were obtained from the Mutant Mouse
Resource & Research Center and were backcrossed to a C57BL/6J back-
ground. Additional information is provided in Supplemental Experimental
Procedures. Mice were housed in the Interfacultary Biomedical Facility of Hei-
delberg University according to institutional guidelines. All animal experiments
were carried out according to the German Animal Protection Law and with
permission of the Regierungspraesidium Karlsruhe (T-57/16). Retrograde
tracing experiments were conducted at the University of Cambridge in accor-
dance with the United Kingdom Animal (Scientific Procedures) Act 1986
Amendment Regulations 2012 under a Project License (70/7705) granted to
E.S.S. by the Home Office; the University of Cambridge Animal Welfare Ethical
Review Body also approved procedures.
Immunohistochemistry
A detailed description of the immunostaining protocols and the antibodies that
were used is provided in Supplemental Experimental Procedures.
Cell Culture
DRG neurons from 8- to 12-week-old mice were cultured on glass coverslips
coated with poly-L-lysine and laminin in DMEM-F12 medium supplemented
with L-glutamine (2 mM), glucose (8mg/mL), penicillin (200U/mL)-streptomycin
(200 mg/mL), and 5% fetal horse serum. Detailed information about the prepa-
ration of DRG cultures is provided in Supplemental Experimental Procedures.
Patch-Clamp Recordings
Whole-cell patch-clamp recordings were made at 20C–24C with an EPC10
amplifier (HEKA) and patch pipettes with a resistance of 2–4 MU. Neurons
were clamped at a holding potential of 60 mV and stimulated with a series
of mechanical stimuli in 1.6 mm increments with a fire-polished glass pipette
(tip diameter 2–3 mm) that was positioned at an angle of 45 to the surface of
the dish and moved with a velocity of 3.5 mm/ms by a piezo-driven microma-
nipulator (MM3A; Kleindiek Nanotechnik). Additional information is provided in
Supplemental Experimental Procedures.
Retrograde Labeling
A detailed description of the retrograde labeling procedure is provided in Sup-
plemental Experimental Procedures.
Single-Cell Electroporation and siRNA-Mediated Knockdown
CHRNA3+ neurons were transfected with non-targeting siRNA (D-001810-01-
05 ON-TARGETplus non-targeting siRNA; GE Healthcare) and PIEZO2-
siRNA (L-163012-00-0005 ON-TARGETplus Mouse Piezo2 [667742] siRNA;
SMARTpool), respectively, using single-cell electroporation. Details about
the electroporation procedure are provided in Supplemental Experimental
Procedures.
Reverse Transcription and Real-Time qPCR
mRNA expression levels of candidate mechanotransduction genes in
CHRNA3+ neurons were determined from samples containing 20 CHRNA3+
neurons that were collected from DRG cultures by aspirating the cells into a
patch-clamp pipette filled with 2–4 mL PBS containing 4 U/mL RNaseOUT
(Thermo Fisher Scientific). cDNA synthesis was carried out directly on the sam-
ple using the Power SYBR Green Cells-to-CT Kit (Life Technologies) following
the manufacturer’s instructions. qPCRs were performed using FastStart
Essential DNA Green Master (Roche) on a LightCycler 96 (Roche). Detailed in-
formation about primers and thermal cycle profile is provided in Supplemental
Experimental Procedures.
Statistical Analysis
All statistical analyses were made using GraphPad Prism 5. The statistical
tests that were used are mentioned in the figure legends and in the main
text, respectively. To select the appropriate test, all datasets were tested for
Gaussian distribution using the Kolmogorov-Smirnov test. N indicates
the number of animals that were used; n indicates the number of cells.
*p < 0.05, #p < 0.05, and xp < 0.05; **p < 0.01, ##p < 0.01, and xxp < 0.01;
***p < 0.001, ###p < 0.001, and xxxp < 0.001; ns, not significant (p > 0.05).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at https://doi.org/
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